Tag Archives: Bernie Sanders

Health stocks shine on Wall Street as Medicare for All shows signs of slippage.

Support for Medicare for All is showing signs of slippage as top-tier Democratic presidential candidates Sens. Elizabeth Warren and Bernie Sanders struggle to sell the proposal without providing specifics on… Read more »

The worldwide battle over health spending, especially high drug prices, and whether it’s actually worth it. The view from afar.

Commentary: Steve Walker The “Medicare for All” plan embraced by leading 2020 Democrats looks more lavish than what other advanced countries offer, compounding the cost but also potentially broadening its… Read more »

Health stocks mount furious comeback after getting crushed by jitters about Medicare for All, the fate of the ACA and threats of new drug-pricing rules.

Here we go again. The S&P 500 healthcare sector fell 4.4% two weeks ago, its worst weekly decline since late December. The move ended with more than 93% of healthcare stocks trading… Read more »

GOP Sen. Alexander’s plucky, bipartisan bill to fix Obamacare headed to Senate vote this week; does this dark horse have a chance in such a crowded field?

The News: The month of September has been blitzed with healthcare bills. Last week alone, Democrat and Republican senators introduced both a single-payer plan and an Affordable Care Act (ACA) repeal and replacement… Read more »

PTC Therapeutics catches falling knife with Emflaza buy; or did it?

Every now and again I’ll read about what seems on its face a boneheaded business deal between two Pharma companies and try to blow the lid off some super-stealthy, strategic,… Read more »

Marathon’s defense of pricey orphan drug getting spotlight in Congress; running a marathon is far easier, and a lot cheaper

Steve’s Take: Marathon Pharmaceuticals LLC (Northbrook IL) caught my attention last month at the inception of an outcry when the company first announced the $89,000 price tag for its newly… Read more »

Trump and pharma execs make nice; what, Sen. Sanders too?

The News: Last week (January 30, 2017), President Trump promised some of the nation’s top drug-company executives in a meeting at the White House that he would shrink Food and… Read more »

Trump’s HHS cabinet pick eludes Congress’s Q&A about Trumpcare specifics; questionable stock investments obscure his suitability to run the US health show

The News: Georgia Rep. Tom Price, President Trump’s choice for secretary of the Department of Health and Human Services, on Tuesday rejected conflict of interest and abuse of power accusations related to… Read more »

Japan’s Takeda leads off 2017 M&A season with gutsy deal to buy US cancer specialist Ariad for $5.2 billion; it’s expensive, but probably worth it

Japan’s Takeda Pharmaceutical Co. Ltd. agreed to acquire Ariad Pharmaceuticals Inc. (Cambridge MA) for $24 per share in cash, or an enterprise value of approximately $5.2 billion, boosting its oncology… Read more »